Literature DB >> 15007595

Corticosteroid-serotonin interactions in depression: a review of the human evidence.

Richard J Porter1, Peter Gallagher, Stuart Watson, Allan H Young.   

Abstract

RATIONALE: It has been suggested that corticosteroid-serotonin interactions are central to the pathophysiology of depression. These interactions have been investigated in healthy and depressed humans, primarily using neuroendocrine techniques.
OBJECTIVES: To review the evidence regarding the nature of these interactions in healthy and depressed humans.
METHODS: Electronic searches were performed for relevant papers, employing MEDLINE and Web of Science. To focus the review, we selected only those articles involving (i) assessment of serotonergic function following experimental manipulation of the HPA axis in healthy volunteers; and (ii) assessment of both serotonergic and HPA axis function in clinically depressed subjects.
RESULTS: Pre-treatment with hydrocortisone, both acutely and sub-acutely attenuates the GH response to GHRH in healthy subjects. This complicates the interpretation of 5-HT neuroendocrine studies employing GH output as a measure. In depression there is evidence that reduced availability of l-tryptophan impairs HPA axis feedback. There is also evidence that depressed and healthy subjects may adapt differently both to low tryptophan and hypercortisolaemic challenges. There is no consistent evidence of a simple relationship between HPA axis function and 5-HT function in depression.
CONCLUSIONS: The putative reduction in central 5-HT function has not been shown to be a direct consequence of hypercortisolaemia. Rather, the 5-HT system and HPA axis have complex inter-relationships. Challenges to either system, such as stress or reduced dietary tryptophan, may perturb the other and subjects vulnerable to depression may fail to adapt to such challenges.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15007595     DOI: 10.1007/s00213-004-1774-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  141 in total

1.  Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine.

Authors:  W J Inder; T C Prickett; R T Mulder; R A Donald; P R Joyce
Journal:  Psychopharmacology (Berl)       Date:  2001-06       Impact factor: 4.530

Review 2.  Growth hormone axis in cushing's syndrome.

Authors:  B L Wajchenberg; B Liberman; D Giannella Neto; M Y Morozimato; M Semer; L O Bracco; L R Salgado; M Knoepfelmacher; M H Borges; A C Pinto; C E Kater; A M Lengyel
Journal:  Horm Res       Date:  1996

3.  Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans.

Authors:  K P Lesch; R Rupprecht; B Poten; U Müller; K Söhnle; J Fritze; H M Schulte
Journal:  Biol Psychiatry       Date:  1989-06       Impact factor: 13.382

4.  Effect of hydrocortisone on the pituitary response to growth hormone releasing hormone.

Authors:  S Watson; R J Porter; A H Young
Journal:  Psychopharmacology (Berl)       Date:  2000-09       Impact factor: 4.530

5.  Impact of cortisol on buspirone stimulated prolactin release: a double-blind placebo-controlled study.

Authors:  T G Dinan; L V Scott; J Thakore; J Naesdal; P W Keeling
Journal:  Psychoneuroendocrinology       Date:  2001-10       Impact factor: 4.905

6.  The effects of glucocorticoids on the availability of L-tryptophan and tyrosine in the plasma of depressed patients.

Authors:  M Maes; C Schotte; S Scharpé; M Martin; P Blockx
Journal:  J Affect Disord       Date:  1990-02       Impact factor: 4.839

7.  HPA axis dysfunction in depression: correlation with monoamine system abnormalities.

Authors:  M C Mokrani; F Duval; M A Crocq; P Bailey; J P Macher
Journal:  Psychoneuroendocrinology       Date:  1997       Impact factor: 4.905

8.  Lowering cortisol enhances growth hormone response to growth hormone releasing hormone in healthy subjects.

Authors:  T G Dinan; J Thakore; V O'Keane
Journal:  Acta Physiol Scand       Date:  1994-07

9.  The human growth hormone response to clonidine: relationship to clinical and neuroendocrine profile in depression.

Authors:  R J Dolan; S P Calloway
Journal:  Am J Psychiatry       Date:  1986-06       Impact factor: 18.112

10.  Depending on the time of administration, dexamethasone potentiates or blocks growth hormone-releasing hormone-induced growth hormone release in man.

Authors:  F F Casanueva; B Burguera; M A Tome; L Lima; J A Tresguerres; J Devesa; C Dieguez
Journal:  Neuroendocrinology       Date:  1988-01       Impact factor: 4.914

View more
  34 in total

Review 1.  The Adaptive Calibration Model of stress responsivity.

Authors:  Marco Del Giudice; Bruce J Ellis; Elizabeth A Shirtcliff
Journal:  Neurosci Biobehav Rev       Date:  2010-12-08       Impact factor: 8.989

Review 2.  The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention.

Authors:  Maurizio Pompili; Gianluca Serafini; Marco Innamorati; Anne Maria Möller-Leimkühler; Giancarlo Giupponi; Paolo Girardi; Roberto Tatarelli; David Lester
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02-20       Impact factor: 5.270

Review 3.  [The significance of stress: its role in the auditory system and the pathogenesis of tinnitus].

Authors:  B Mazurek; T Stöver; H Haupt; B F Klapp; M Adli; J Gross; A J Szczepek
Journal:  HNO       Date:  2010-02       Impact factor: 1.284

4.  Genome-wide approaches to antidepressant treatment: working towards understanding and predicting response.

Authors:  Karen Hodgson; Shaista Jeelani Mufti; Rudolf Uher; Peter McGuffin
Journal:  Genome Med       Date:  2012-06-27       Impact factor: 11.117

Review 5.  Stress and the reproductive axis.

Authors:  D Toufexis; M A Rivarola; H Lara; V Viau
Journal:  J Neuroendocrinol       Date:  2014-09       Impact factor: 3.627

Review 6.  Genetic and early environmental influences on the serotonin system: consequences for brain development and risk for psychopathology.

Authors:  Linda Booij; Richard E Tremblay; Moshe Szyf; Chawki Benkelfat
Journal:  J Psychiatry Neurosci       Date:  2015-01       Impact factor: 6.186

7.  A translational approach to clinical practice via stress-responsive glucocorticoid receptor signaling.

Authors:  Mario F Juruena; Bruno Agustini; Anthony J Cleare; Allan H Young
Journal:  Stem Cell Investig       Date:  2017-02-16

8.  Differential effects of 5-HTTLPR genotypes on mood, memory, and attention bias following acute tryptophan depletion and stress exposure.

Authors:  Christine Firk; C Rob Markus
Journal:  Psychopharmacology (Berl)       Date:  2008-12-16       Impact factor: 4.530

9.  HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression.

Authors:  Ian H Gotlib; Jutta Joormann; Kelly L Minor; Joachim Hallmayer
Journal:  Biol Psychiatry       Date:  2007-11-19       Impact factor: 13.382

10.  Serotonin transporter gene variation, infant abuse, and responsiveness to stress in rhesus macaque mothers and infants.

Authors:  K McCormack; T K Newman; J D Higley; D Maestripieri; M M Sanchez
Journal:  Horm Behav       Date:  2009-02-03       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.